BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 20061461)

  • 1. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Prueitt RL; Beck BD
    Hum Exp Toxicol; 2010 Jan; 29(1):7-9. PubMed ID: 20061461
    [No Abstract]   [Full Text] [Related]  

  • 2. An integrated summary of commentary on the National Academy of Sciences report on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Gibson JE
    Hum Exp Toxicol; 2010 Jan; 29(1):33-5. PubMed ID: 20061466
    [No Abstract]   [Full Text] [Related]  

  • 3. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Waddell WJ
    Hum Exp Toxicol; 2010 Jan; 29(1):31-2. PubMed ID: 20061465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Phalen RF
    Hum Exp Toxicol; 2010 Jan; 29(1):11-4. PubMed ID: 20061462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Schwartz SL
    Hum Exp Toxicol; 2010 Jan; 29(1):15-9. PubMed ID: 20061463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy'': stem cells and cell-cell communication as fundamental targets in assessing the potential toxicity of chemicals.
    Trosko JE
    Hum Exp Toxicol; 2010 Jan; 29(1):21-9. PubMed ID: 20061464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicology in the 21st century--working our way towards a visionary reality.
    Berg N; De Wever B; Fuchs HW; Gaca M; Krul C; Roggen EL
    Toxicol In Vitro; 2011 Jun; 25(4):874-81. PubMed ID: 21338664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity testing in the 21st century--a view from BELLE.
    Calabrese EJ
    Hum Exp Toxicol; 2010 Jan; 29(1):5-6. PubMed ID: 20061460
    [No Abstract]   [Full Text] [Related]  

  • 9. How omics technologies can contribute to the '3R' principles by introducing new strategies in animal testing.
    Kroeger M
    Trends Biotechnol; 2006 Aug; 24(8):343-6. PubMed ID: 16782220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new revolution in toxicology: the good, the bad, and the ugly.
    Davis M; Boekelheide K; Boverhof DR; Eichenbaum G; Hartung T; Holsapple MP; Jones TW; Richard AM; Watkins PB
    Ann N Y Acad Sci; 2013 Mar; 1278():11-24. PubMed ID: 23488558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory toxicology in the twenty-first century: challenges, perspectives and possible solutions.
    Tralau T; Oelgeschläger M; Gürtler R; Heinemeyer G; Herzler M; Höfer T; Itter H; Kuhl T; Lange N; Lorenz N; Müller-Graf C; Pabel U; Pirow R; Ritz V; Schafft H; Schneider H; Schulz T; Schumacher D; Zellmer S; Fleur-Böl G; Greiner M; Lahrssen-Wiederholt M; Lampen A; Luch A; Schönfelder G; Solecki R; Wittkowski R; Hensel A
    Arch Toxicol; 2015 Jun; 89(6):823-50. PubMed ID: 25820917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Call to curb lab tests on dogs.
    Turner M
    Nature; 2011 Jun; 474(7353):551. PubMed ID: 21720337
    [No Abstract]   [Full Text] [Related]  

  • 13. An animal protection perspective on 21st century toxicology.
    Stephens ML
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):291-8. PubMed ID: 20574903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation challenges for designing integrated in vitro testing strategies (ITS) aiming at reducing and replacing animal experimentation.
    De Wever B; Fuchs HW; Gaca M; Krul C; Mikulowski S; Poth A; Roggen EL; Vilà MR
    Toxicol In Vitro; 2012 Apr; 26(3):526-34. PubMed ID: 22269383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein biomarkers for in vitro testing of toxicology.
    Schrattenholz A; Šoškić V; Schöpf R; Poznanović S; Klemm-Manns M; Groebe K
    Mutat Res; 2012 Aug; 746(2):113-23. PubMed ID: 22405942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing the National Academy's Vision and Strategy for Toxicity Testing: opportunities and challenges under the U.S. Toxic Substances Control Act.
    Locke PA; Bruce Myers D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):376-84. PubMed ID: 20574909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity testing in the 21st century: how will it affect risk assessment?
    Rhomberg LR
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):361-75. PubMed ID: 20574908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EU research activities in alternative testing strategies: current status and future perspectives.
    Vanhaecke T; Snykers S; Rogiers V; Garthoff B; Castell JV; Hengstler JG
    Arch Toxicol; 2009 Dec; 83(12):1037-42. PubMed ID: 19908029
    [No Abstract]   [Full Text] [Related]  

  • 19. Current standing and future prospects for the technologies proposed to transform toxicity testing in the 21st century.
    van Vliet E
    ALTEX; 2011; 28(1):17-44. PubMed ID: 21311848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Food for Thought ... on mapping the human toxome.
    Hartung T; McBride M
    ALTEX; 2011; 28(2):83-93. PubMed ID: 21625825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.